Another important alteration in the leukemic TME is the increased levels of anti-inflammatory and immunosuppressive cytokines, such as IL-10 and TGF-β, and the high expression of PD-1 and TIGIT, which contribute to tumor progression and immune evasion (43, 47, 55, 194). The gene discussed is TGFB1; the disease is neoplasm.